- Home
- ESEA vs VYGR Comparison
ESEA vs VYGR Comparison
Compare ESEA & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESEA
- VYGR
- Stock Information
- Founded
- ESEA 2005
- VYGR 2013
- Country
- ESEA Greece
- VYGR United States
- Employees
- ESEA N/A
- VYGR N/A
- Industry
- ESEA Marine Transportation
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- ESEA Consumer Discretionary
- VYGR Health Care
- Exchange
- ESEA Nasdaq
- VYGR Nasdaq
- Market Cap
- ESEA 208.2M
- VYGR 172.6M
- IPO Year
- ESEA 2006
- VYGR 2015
- Fundamental
- Price
- ESEA $48.62
- VYGR $3.57
- Analyst Decision
- ESEA Strong Buy
- VYGR Strong Buy
- Analyst Count
- ESEA 1
- VYGR 8
- Target Price
- ESEA $62.00
- VYGR $14.33
- AVG Volume (30 Days)
- ESEA 52.4K
- VYGR 712.5K
- Earning Date
- ESEA 08-05-2025
- VYGR 08-05-2025
- Dividend Yield
- ESEA 5.50%
- VYGR N/A
- EPS Growth
- ESEA 21.86
- VYGR N/A
- EPS
- ESEA 18.62
- VYGR N/A
- Revenue
- ESEA $222,525,034.00
- VYGR $66,958,000.00
- Revenue This Year
- ESEA $5.14
- VYGR N/A
- Revenue Next Year
- ESEA $3.76
- VYGR $78.88
- P/E Ratio
- ESEA $2.64
- VYGR N/A
- Revenue Growth
- ESEA 14.62
- VYGR N/A
- 52 Week Low
- ESEA $24.58
- VYGR $2.65
- 52 Week High
- ESEA $50.82
- VYGR $9.55
- Technical
- Relative Strength Index (RSI)
- ESEA 61.35
- VYGR 63.79
- Support Level
- ESEA $46.59
- VYGR $3.00
- Resistance Level
- ESEA $50.50
- VYGR $3.43
- Average True Range (ATR)
- ESEA 1.84
- VYGR 0.18
- MACD
- ESEA -0.13
- VYGR 0.06
- Stochastic Oscillator
- ESEA 53.62
- VYGR 97.50
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.